Marasco G, Dajti E, Ravaioli F, Brocchi S, Rossini B, Alemanni LV, et al
[15] [39] [40] In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
Because they can reduce caloric consumption, you might be missing out on necessary nutrients
Elevated dopamine feels good, but you can have too much of a good thing and become desensitized to it, gradually requiring higher doses, more frequently, to achieve the same effect
At scale, it is anything but